Results 151 to 160 of about 26,025 (223)

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature. [PDF]

Ann Hematol
Dereme J, Segot A, Nabergoj M, Dewarrat N, Basset V, Blum S, Tsilimidos G.   +6 more
europepmc   +1 more source

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL. [PDF]

Blood Adv
Shadman M, Tam CS, Brander DM, Lefebure M, Yang K, Xu S, Tian T, Kuptsova-Clarkson N, Williams R, Hirata J, Munir T.   +10 more
europepmc   +1 more source

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy [PDF]

, 2018
Coats, Josh, Collins, Graham P., Cross, Matthew, Dyer, Martin J. S., Eyre, Toby A., Follows, George, Fox, Christopher P., Hodson, Andrew, Iyengar, Sunil, Morley, Nick, Narat, Santosh, Walter, Harriet S.   +11 more
core   +3 more sources

Disproportionality Analysis of Hematologic Adverse Event Signals Associated with Venetoclax in Combination with Senescence-Inducing Chemotherapy. [PDF]

J Clin Med
Saleh T, Ramadan M, Alsoud A, Al Shboul S.   +3 more
europepmc   +1 more source

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML. [PDF]

Blood Cancer J
Swain RN, Jain A, Wadhera S, Singh C, Jandial A, Khadwal A, Sachdeva MU, Naseem S, Malhotra P, Prakash G.   +9 more
europepmc   +1 more source

Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia. [PDF]

Ann Hematol
Morelli F, Linari S, Rapolla CM, Attanasio M, Salvianti F, Sanna A.   +5 more
europepmc   +1 more source

Does age matter? Optimizing AML treatment in older adults. [PDF]

Blood Adv
Lai C, Lin TL.
europepmc   +1 more source

PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts [PDF]

, 2018
AM Abdul-Aziz, B Vick, CR Marlein, E Lou, EM Stein, J Lu, J Pasquier, MS Shafat, PJ Fernandez-Marcos, R Moschoi, RC Rabinovitch, S Andrzejewski, S Jager, VS LeBleu   +13 more
core   +1 more source

Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALL. [PDF]

Cell Death Dis
Fortner C, Niedermayer A, Bäuerle MM, Wichert MC, Braun CJ, Debatin KM, Vogler M, Meyer LH, Seyfried F.   +8 more
europepmc   +1 more source

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. [PDF]

J Pers Med
Ko KH, Gelfer R, Wheat JC, Cai SF.
europepmc   +1 more source